Research study Program year 2021 Source: CMS Open Payments

Bioequivalence study

Research payments

$359,787

27 payments

Through program year 2021, $359,787 in research payments was reported against Bioequivalence study, across 27 payments, paid by Perrigo Company plc.

Paid by: Perrigo Company plc
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$359,787	27

Breakdown

Who paid Research payments · program year 2021

Perrigo Company plc $359,787 27 payments

Who received the money Research payments · program year 2021

Clayton Eye Clinical Research, LLC Organisation paid for research $115,875 5 payments
Total Eye Care, PA Organisation paid for research $74,750 3 payments
APF Research, LLC Organisation paid for research $71,150 4 payments
Central Florida Eye Associates Organisation paid for research $49,800 2 payments
Eye Research Foundation, Inc. Organisation paid for research $21,500 2 payments
Ophthalmology Associates Organisation paid for research $11,500 4 payments
Recipient not identified in the record $5,220 2 payments
AdvanceMed Clinical Research Organisation paid for research $4,500 1 payment
Lakeside Vision Center Organisation paid for research $2,500 1 payment
Mark J. Weiss, M.D., Inc. Organisation paid for research $2,500 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.